Status:
COMPLETED
Clinical Relevance of the Salvage Treatment for Colorectal Neuroendocrine Tumors
Lead Sponsor:
Yanhong Deng
Conditions:
Rectal Neoplasms
Neuroendocrine Tumors
Eligibility:
All Genders
18-65 years
Brief Summary
we evaluated all related clinical and pathologic data of rectal NET cases, including the resection margin status, NET grading, and lymphovascular invasion status. Finally, the present study was aimed ...
Eligibility Criteria
Inclusion
- within the age range of 18 to 65 years, diagnosed with rectal neuroendocrine tumors. Furthermore, patients were required to have a palpable tumor as determined by digital rectal examination or accessible through proctoscopy, with the distal border situated within 12 cm from the anal verge.
Exclusion
- (1) muscularis propria invasion or NET grading = 3, (2)regional LN or distant organs metastasis at the time of diagnosis, (3) incomplete follow-up information, (4) the patient had multiple primary tumors, (5) patients with surgical excision or inappropriate methods such as forceps removal, and (6) the patient had a history of malignant tumors.
Key Trial Info
Start Date :
January 30 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
527 Patients enrolled
Trial Details
Trial ID
NCT06143605
Start Date
January 30 2013
End Date
September 30 2023
Last Update
November 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.